Recombinant multi-species RSK2/RPS6KA3/RSK3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RSK2/RPS6KA3/RSK3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). [provided by RefSeq, Jul 2008]
The Alternative Names of target: 90 kDa ribosomal protein S6 kinase 3 (p90-RSK 3,CLS,HU-3,ISPK-1,Insulin-stimulated protein kinase 1 (ISPK-1),MAP kinase-activated protein kinase 1b (MAPK-activated protein kinase 1b,MAPKAP kinase 1b,MAPKAPK-1b,MAPKAPK-1b),MAPKAPK1B,MPK-9,MRX19,RGD1563860,RPS6KA3,RSK,RSK2,RSK3,Ribosomal S6 kinase 2 (RSK-2),Ribosomal protein S6 kinase alpha-3,Rps6ka3,Rsk2,S6K-alpha-3,S6K-alpha3,XLID19,p90-RSK2,p90RSK3,p90RSK3),pp90RSK2

Target products collectionGo to RSK2/RPS6KA3/RSK3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T03279-Ag-1/ GM-Tg-hg-T03279-Ag-2 Human RSK2/RPS6KA3/RSK3 protein Human
GM-Tg-rg-T03279-Ag-1/ GM-Tg-rg-T03279-Ag-2 Rat RSK2/RPS6KA3/RSK3 protein Rat
GM-Tg-mg-T03279-Ag-1/ GM-Tg-mg-T03279-Ag-2 Mouse RSK2/RPS6KA3/RSK3 protein Mouse
GM-Tg-cynog-T03279-Ag-1/ GM-Tg-cynog-T03279-Ag-2 Cynomolgus/Rhesus macaque RSK2/RPS6KA3/RSK3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T03279-Ag-1/ GM-Tg-felg-T03279-Ag-2 Feline RSK2/RPS6KA3/RSK3 protein Feline
GM-Tg-cang-T03279-Ag-1/ GM-Tg-cang-T03279-Ag-2 Canine RSK2/RPS6KA3/RSK3 protein Canine
GM-Tg-bovg-T03279-Ag-1/ GM-Tg-bovg-T03279-Ag-2 Bovine RSK2/RPS6KA3/RSK3 protein Bovine
GM-Tg-equg-T03279-Ag-1/ GM-Tg-equg-T03279-Ag-2 Equine RSK2/RPS6KA3/RSK3 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T03279-Ag-1/ GM-Tg-hg-T03279-Ag-2; GM-Tg-rg-T03279-Ag-1/ GM-Tg-rg-T03279-Ag-2;
GM-Tg-mg-T03279-Ag-1/ GM-Tg-mg-T03279-Ag-2; GM-Tg-cynog-T03279-Ag-1/ GM-Tg-cynog-T03279-Ag-2;
GM-Tg-felg-T03279-Ag-1/ GM-Tg-felg-T03279-Ag-2; GM-Tg-cang-T03279-Ag-1/ GM-Tg-cang-T03279-Ag-2;
GM-Tg-bovg-T03279-Ag-1/ GM-Tg-bovg-T03279-Ag-2; GM-Tg-equg-T03279-Ag-1/ GM-Tg-equg-T03279-Ag-2
Products Name RSK2/RPS6KA3/RSK3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RSK2/RPS6KA3/RSK3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RSK2/RPS6KA3/RSK3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.